CLDI

Calidi Biotherapeutics, Inc. Common Stock (CLDI)

About Calidi Biotherapeutics, Inc. Common Stock (CLDI)

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.

Details

Daily high

$1.35

Daily low

$1.29

Price at open

$1.32

52 Week High

$21.24

52 Week Low

$1.10

Market cap

9.5M

Dividend yield

0.00%

Volume

54,126

Avg. volume

78,456

P/E ratio

-.15

Calidi Biotherapeutics, Inc. Common Stock News